PTN and peripheral arterial disease: Despite difficulties in large-scale genetic alteration of muscle by myoblast transplantation, this result holds potential clinical relevance in that the use of muscle-derived stem cells is reported to result in a more robust and wide-spread dissemination through tissue [27], [28]; thus, a cell-mediated delivery of the PTN gene for treatment of peripheral artery disease remains an intriguing possibility.